sb 216763 has been researched along with Pulmonary Hypertension in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alapati, D; Chen, S; Hehre, D; Hummler, SC; Rong, M; Wu, S | 1 |
1 other study(ies) available for sb 216763 and Pulmonary Hypertension
Article | Year |
---|---|
Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
Topics: Airway Remodeling; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hyperoxia; Hypertension, Pulmonary; Indoles; Infant, Newborn; Injections, Intraperitoneal; Lung; Maleimides; Phosphorylation; Pneumonia; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor RelA | 2013 |